close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Alvotech

< Previous 1 2 3 4 5 Next >
News headline image
Alvotech further strengthens liquidity by securing term loan facility of $75 million
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
From Alvotech
Via GlobeNewswire
Tickers ALVO TEVA
News headline image
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
From Alvotech
Via GlobeNewswire
Tickers ALVO TEVA
News headline image
Main Results of 2026 Annual and Extraordinary General Meeting
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech to present at upcoming investor conferences in June
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Q1 2026 Financial Results
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces a Change in its Executive Team
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech to Report Financial Results for the First Quarter of 2026
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Files Annual Report with the SEC
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Q4 2025 and Full Year 2025 Financial Results
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech announces planned CEO succession and leadership transition
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Secures Term Loan Facility of USD 100 Million
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Changes in Global Business Development and Commercial Operations Team
From Alvotech
Via GlobeNewswire
Tickers ALVO
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today